Primary cutaneous lymphomas: diagnosis and treatment

Area of Science:

• Dermatology
• Hematology
• Oncology

Background:

• Primary cutaneous lymphomas (CLs) are a diverse group of lymphoproliferative disorders confined to the skin at diagnosis.
• These conditions involve mature T-lymphocytes (65%), B-lymphocytes (25%), or NK cells, originating in the skin.
• Exclusion of lymph node, bone marrow, or visceral involvement is key at the time of diagnosis.

Purpose of the Study:

• To emphasize the diagnostic and prognostic importance of histopathological evaluation in primary cutaneous lymphomas.
• To highlight the necessity of precise staging and identification of prognostic factors for treatment planning.
• To underscore the role of these elements in evaluating treatment outcomes for cutaneous lymphomas.

Main Methods:

• Histopathological examination of skin biopsy specimens.
• Immunophenotyping of lesional lymphocytes.
• Clinical staging and assessment of prognostic indicators.

Main Results:

• Histopathology and immunophenotyping are fundamental for diagnosing CLs.
• Accurate staging and prognostic factor identification are crucial for guiding therapy.
• These factors aid in selecting optimal treatment and assessing response.

Conclusions:

• Diagnosis of primary cutaneous lymphomas requires a multi-faceted approach.
• Staging and prognostic evaluation are essential for personalized treatment strategies.
• Effective management of CLs depends on accurate diagnosis and risk stratification.